Patrick Hensley, MD (@pjhensley11) 's Twitter Profile
Patrick Hensley, MD

@pjhensley11

Urologic Oncologist at the University of Kentucky. Bladder cancer researcher. Husband and father x3.

ID: 3083982069

calendar_today10-03-2015 13:36:52

183 Tweet

395 Followers

215 Following

Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

Choosing where to do your YUO fellowship is a pivotal decision 🌟 Our MD Anderson Cancer Center fellowship stands out with a trainee-focused program dedicated to your professional growth Enjoy the benefits of a global alumni network + national/international opportunities It's

Joon Kyung Kim, MD 김준경 (@joonkyung_kim) 's Twitter Profile Photo

Such a privilege to have Dr. Kamat Ashish M. Kamat, MD, MBBS as part of the Society of Urologic Oncology SUO Visiting Professor and University of Kentucky Urology Residency Program Bruce Lucas Visiting Professor. Lots of knowledge gained from interactive discussions regarding bladder cancer and there was no better person to lecture us on this topic!

Such a privilege to have Dr. Kamat <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> as part of the <a href="/UroOnc/">Society of Urologic Oncology</a> SUO Visiting Professor and <a href="/UKYurology/">University of Kentucky Urology Residency Program</a> Bruce Lucas Visiting Professor. 

Lots of knowledge gained from interactive discussions regarding bladder cancer and there was no better person to lecture us on this topic!
Patrick Hensley, MD (@pjhensley11) 's Twitter Profile Photo

What is the role of restaging TURBT for HG Ta disease? There exists considerable uncertainty in a room full of bladder cancer experts. Time for a RCT?IBCG #bladdercancer Ashish M. Kamat, MD, MBBS Jeremy Teoh Neal shore Badrinath Konety, MD, MBA Mark Tyson

What is the role of restaging TURBT for HG Ta disease? There exists considerable uncertainty in a room full of bladder cancer experts. Time for a RCT?<a href="/IBCG_BladderCA/">IBCG</a> #bladdercancer <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> <a href="/jteoh_hk/">Jeremy Teoh</a> Neal shore <a href="/bkonety/">Badrinath Konety, MD, MBA</a> <a href="/MarkTysonMD/">Mark Tyson</a>
Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC) Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place #AUA24 #EAU24 #IBCG24 #ASCO24 Designed by Amanda Myers

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place  #AUA24 #EAU24 #IBCG24 #ASCO24

Designed by <a href="/AmandaMyersMD/">Amanda Myers</a>
Eugene Pietzak (@eugene_pietzak) 's Twitter Profile Photo

Huge congrats to Roger Li  & team, CG Oncology, Inc. This is a rigorously designed study with very promising results. Looking forward to seeing how this combo will be further evaluated in future RCTs to determine where it fits in the growing armamentarium I have few questions

UroToday.com (@urotoday) 's Twitter Profile Photo

Defining standard and extended pelvic lymphadenectomy in #BladderCancer surgery. Seth Lerner, MD, FACS BCMHouston & Sia Daneshmand, M.D. Keck Medicine of USC join Patrick Hensley, MD as part of the IBCG #BladderCancerForum in this discussion on UroToday > bit.ly/3VjRpuM

Defining standard and extended pelvic lymphadenectomy in #BladderCancer surgery. Seth Lerner, MD, FACS <a href="/bcmhouston/">BCMHouston</a>  &amp; <a href="/siadaneshmand/">Sia Daneshmand, M.D.</a> <a href="/KeckMedicineUSC/">Keck Medicine of USC</a> join <a href="/pjhensley11/">Patrick Hensley, MD</a> as part of the  <a href="/IBCG_BladderCA/">IBCG</a>  #BladderCancerForum in this discussion on UroToday &gt; bit.ly/3VjRpuM
Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (International Bladder Cancer Group): A Multicenter YAU Urothelial Working Group Collaboration European Urology Oncology Paolo Gontero francesco soria authors.elsevier.com/c/1jIAG9Cfv--d… a🧵

Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (International Bladder Cancer Group): A Multicenter YAU Urothelial Working Group Collaboration <a href="/EurUrolOncol/">European Urology Oncology</a> <a href="/paolo_gontero/">Paolo Gontero</a> <a href="/frasor86/">francesco soria</a> 
authors.elsevier.com/c/1jIAG9Cfv--d…
a🧵
Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

Only two weeks until the #IBCG24 Retreat! Looking forward to welcoming top bladder cancer experts, dedicated patient advocates and partners from around the globe to Houston The retreat chaired by Roger Li Patrick Hensley, MD Shilpa Gupta is all about collaboration: together, we’ll

Only two weeks until the #IBCG24 Retreat! Looking forward to welcoming top bladder cancer experts, dedicated patient advocates and partners from around the globe to Houston

The retreat chaired by <a href="/UrogerliMD/">Roger Li</a> <a href="/pjhensley11/">Patrick Hensley, MD</a> <a href="/shilpaonc/">Shilpa Gupta</a> is all about collaboration: together, we’ll
European Urology Oncology (@eururoloncol) 's Twitter Profile Photo

Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function by Patrick Hensley, MD, Craig Labbate et al Full article: buff.ly/4ixpTDO #UroSoMe #MedTwitter #EUO

Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function by <a href="/pjhensley11/">Patrick Hensley, MD</a>, <a href="/labbdoc/">Craig Labbate</a> et al

Full article: buff.ly/4ixpTDO 

#UroSoMe #MedTwitter #EUO
Bogdana Schmidt MD, MPH (@bogdanaschmidt) 's Twitter Profile Photo

Inclusive clinical trials are absolutely vital to generalizable data and they provide better care to underrepresented patients! Masterclass by Yaw Nyame at #MaTOSGU25 🌟 pick the right partners 🌟 have clear goals 🌟 compensate people for their time 💡 frameworks exist!

Inclusive clinical trials are absolutely vital to generalizable data and they provide better care to underrepresented patients! 
Masterclass by <a href="/yawnyame/">Yaw Nyame</a> at #MaTOSGU25
🌟 pick the right partners
🌟 have clear goals
🌟 compensate people for their time
💡 frameworks exist!
UroToday.com (@urotoday) 's Twitter Profile Photo

Optimizing patient selection and treatment timing with emerging intravesical therapies: the case of nadofaragene firadenovec. Patrick Hensley, MD The University of Kansas Department of Urology sits down with Sam S. Chang MD, MBA Vanderbilt Urology sharing insights on nadofaragene firadenovec, from operational improvements to patient

Optimizing patient selection and treatment timing with emerging intravesical therapies: the case of nadofaragene firadenovec. <a href="/pjhensley11/">Patrick Hensley, MD</a> <a href="/Urology_KU/">The University of Kansas Department of Urology</a> sits down with <a href="/UroCancerMD/">Sam S. Chang MD, MBA</a> <a href="/VUMCurology/">Vanderbilt Urology</a> sharing insights on nadofaragene firadenovec, from operational improvements to patient
UroToday.com (@urotoday) 's Twitter Profile Photo

#AUA25 Highlights: Advances in #NMIBC. Patrick Hensley, MD & Janet Kukreja join Sam S. Chang MD, MBA highlighting three major BCG-unresponsive CIS trials 🔹 BCG-unresponsive CIS: – Anktiva+BCG: 71% CR – CG0070 (BOND-003): 76% ORR – TAR-200 (SunRISe-1): 82% response 🧠 Surprise: #CISTO shows